Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Supernus Pharmaceuticals buy marge

Supernus Pharmaceuticals
Start price
€14.50
21.06.15 / 50%
Target price
€18.00
22.07.15
Performance (%)
24.25%
End price
€18.02
22.07.15
Summary
This prediction ended on 22.07.15 with a price of €18.02. The BUY prediction by marge finished with a performance of 24.25%. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Supernus Pharmaceuticals -4.186% -4.186% 44.056% 24.848%
iShares Core DAX® 0.985% 8.314% 7.032% 49.791%
iShares Nasdaq 100 2.067% 16.765% 35.952% 96.632%
iShares Nikkei 225® 2.270% 15.605% 46.568% 69.047%
iShares S&P 500 1.043% 11.077% 26.456% 68.087%

Comments by marge for this prediction

In the thread Supernus Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 24.25%
Target price 18.000
Change
Ends at 22.07.15

Supernus

Aus meinem Langfristportofolio mit den Large-cap biotechs:

1.Gilead Science (40%)

2. Amgen (15%)

3. Celgene (25%),

und den smaller-cap biotechs:

Isis Pharmaceuticals, ChemoCentryx, Acceleron,

Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%

Nachfragen zu den einzelnen Werten beantworte ich gerne.

marge 
0
Report Share
21.06.15
Prediction Buy
Perf. (%) 24.25%
Target price 18.000
Change
Ends at 22.07.15

(Vom Mitglied beendet)

marge 
0
Report Share
22.07.15